YU174491A - Vakcine - Google Patents

Vakcine

Info

Publication number
YU174491A
YU174491A YU174491A YU174491A YU174491A YU 174491 A YU174491 A YU 174491A YU 174491 A YU174491 A YU 174491A YU 174491 A YU174491 A YU 174491A YU 174491 A YU174491 A YU 174491A
Authority
YU
Yugoslavia
Prior art keywords
vaccines
immunotherapeutic
mpl
supplemented
preparations
Prior art date
Application number
YU174491A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
F. Van Wijhendale
M. Slaoui
C. Bruck
M. Francotte
S. Kummert
Original Assignee
Smit Kline Beesham Biologicals (S.A)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smit Kline Beesham Biologicals (S.A) filed Critical Smit Kline Beesham Biologicals (S.A)
Publication of YU174491A publication Critical patent/YU174491A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
YU174491A 1991-03-21 1991-11-01 Vakcine YU174491A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919106048A GB9106048D0 (en) 1991-03-21 1991-03-21 Vaccines

Publications (1)

Publication Number Publication Date
YU174491A true YU174491A (sh) 1994-06-10

Family

ID=10691984

Family Applications (1)

Application Number Title Priority Date Filing Date
YU174491A YU174491A (sh) 1991-03-21 1991-11-01 Vakcine

Country Status (12)

Country Link
CN (1) CN1064891A (fr)
AP (1) AP368A (fr)
BR (1) BR9107294A (fr)
CZ (1) CZ195793A3 (fr)
FI (1) FI934133A (fr)
GB (1) GB9106048D0 (fr)
HU (2) HU9302642D0 (fr)
IL (1) IL99899A0 (fr)
MA (1) MA22381A1 (fr)
SK (1) SK82593A3 (fr)
WO (1) WO1992016556A1 (fr)
YU (1) YU174491A (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
US6620414B2 (en) 1992-03-27 2003-09-16 Smithkline Beecham Biologicals (S.A.) Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
ATE157882T1 (de) * 1993-03-23 1997-09-15 Smithkline Beecham Biolog 3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
GB9706957D0 (en) 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
GB9820525D0 (en) 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
CN1304580C (zh) * 2004-07-09 2007-03-14 楼伟 重组表达人获得性免疫缺陷病毒I型的表面糖蛋白gp160
EP1778725B1 (fr) * 2004-07-23 2010-12-29 Novartis Vaccines and Diagnostics S.r.l. Polypeptides pour assemblage oligomere d'antigenes
CN102657855B (zh) 2004-09-22 2015-12-09 葛兰素史密丝克莱恩生物有限公司 用于进行抗葡萄球菌接种的免疫原性组合物
WO2008104803A2 (fr) 2007-02-26 2008-09-04 Oxford Genome Sciences (Uk) Limited Protéines
EP2121745A2 (fr) 2007-02-26 2009-11-25 Oxford Genome Sciences (UK) Limited Protéines
JP2012515544A (ja) 2009-01-21 2012-07-12 オックスフォード ビオトヘラペウトイクス エルティーディー. Pta089タンパク質
EP2496605A1 (fr) 2009-11-02 2012-09-12 Oxford Biotherapeutics Ltd. Ror1 comme cible thérapeutique et diagnostique
RS55716B1 (sr) 2011-06-28 2017-07-31 Oxford Biotherapeutics Ltd Terapeutski i dijagnostički cilj
GB201213364D0 (en) 2012-07-27 2012-09-12 Glaxosmithkline Biolog Sa Purification process
GB201213652D0 (en) 2012-08-01 2012-09-12 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
GB201302447D0 (en) 2013-02-12 2013-03-27 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
US20180071380A1 (en) 2015-03-20 2018-03-15 The Regents Of The University Of Michigan Immunogenic compositions for use in vaccination against bordetella
CA3023672A1 (fr) 2016-05-16 2017-11-23 Infectious Disease Research Institute Liposomes pegyles et procedes d'utilisation
US11344619B2 (en) 2016-05-16 2022-05-31 Access To Advanced Health Institute Formulation containing TLR agonist and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89567A0 (en) * 1988-03-28 1989-09-10 Univ Leland Stanford Junior Mutated hiv envelope protein

Also Published As

Publication number Publication date
GB9106048D0 (en) 1991-05-08
CN1064891A (zh) 1992-09-30
HU9302642D0 (en) 1994-01-28
HUT67011A (en) 1995-01-30
WO1992016556A1 (fr) 1992-10-01
CZ195793A3 (en) 1994-05-18
MA22381A1 (fr) 1992-07-01
AP9100332A0 (en) 1992-01-31
IL99899A0 (en) 1992-08-18
SK82593A3 (en) 1994-01-12
BR9107294A (pt) 1994-06-14
FI934133A0 (fi) 1993-09-21
FI934133A (fi) 1993-09-21
AP368A (en) 1994-10-28

Similar Documents

Publication Publication Date Title
YU174491A (sh) Vakcine
UA40597C2 (uk) Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
ITFI920058A1 (it) Composti coniugati formati da proteine heat shock (hsp) e oligo-polisaccaridi, loro uso per la produzione di vaccini.
DE69620877T2 (de) Arzneimittelformulierungen für il-12
AU1955088A (en) Avirulent microbes, incapable of producing functional adenylate cyclase and cyclic AMP
TR199802329T2 (xx) Enfeksiyon hastal�klar�n�n tedavisinde IL-12 ve IFNalfa kullan�m�.
HUP9801242A1 (hu) Hepatitis B vakcina
NO941786L (no) Uretaner og ureaer som induserer cytokinproduksjon
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
NL300183I1 (nl) Acellulair vaccin.
PT97905A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados da cistina
PT789590E (pt) Imunopotenciacao induzida por quitosano
DE69636285D1 (de) ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF
GR920100570A (el) Παραγωγα 3(2η)-πυριδαζινονης και μεθοδος για την παρασκευη τους.
DE69414810D1 (de) Rapamycin-Zubereitungen zur oralen Verabreichung
PT600396E (pt) Vacinas contra protozoarios intestinais
WO1992006113A3 (fr) DERIVES DE gp160 ET VACCINS A BASE DE gp160 OU D'UN DE SES DERIVES, CONTENANT UN ADJUVANT
ES2159287T3 (es) Peptidos hemorreguladores.
ATE318300T1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
NO933628L (no) Fremgangsmaate og blanding for behandling av Herpes-infeksjoner
NO933342L (no) Derivater av gp160 og vaksiner basert paa gp160 eller et derivat derav, inneholdende et adjuvans
BG102083A (en) Compositions and methods for the detection and treatment of aids